Çağatay Yılmaz (Çağatay Yilmaz)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Pharmaceuticals (Basel, Switzerland)

Naunyn-Schmiedeberg's archives of pharmacology

Toxicology research

This page only lists publications with an associated author ORCID identifier.

Publications

Zerrin Barut, Mutay Aslan, Bürke Çırçırlı, Tuğçe Çeker, Çağatay Yılmaz
Antiproliferative Effect of 7-Ketositosterol in Breast and Liver Cancer Cells: Possible Impact on Ceramide, Extracellular Signal-Regulated Kinases, and Nuclear Factor Kappa B Signaling Pathways. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Zerrin Barut, Mutay Aslan, Bürke Çırçırlı, Tuğçe Çeker, Çağatay Yılmaz
Antiproliferative Effect of 7-Ketositosterol in Breast and Liver Cancer Cells: Possible Impact on Ceramide, Extracellular Signal-Regulated Kinases, and Nuclear Factor Kappa B Signaling Pathways. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Zerrin Barut, Mutay Aslan, Bürke Çırçırlı, Tuğçe Çeker, Çağatay Yılmaz
Antiproliferative Effect of 7-Ketositosterol in Breast and Liver Cancer Cells: Possible Impact on Ceramide, Extracellular Signal-Regulated Kinases, and Nuclear Factor Kappa B Signaling Pathways. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Tuğçe Çeker, Çağatay Yılmaz, Esma Kırımlıoglu, Mutay Aslan
Endoplasmic-reticulum-stress-induced lipotoxicity in human kidney epithelial cells. Toxicology research 11 (4) (2022)
Çağatay Yılmaz, Sadi Köksoy, Tuğçe Çeker, Mutay Aslan
Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells. Naunyn-Schmiedeberg's archives of pharmacology 394 (11) (2021)